Purpose
Guide for parents and caregivers to ensure their child is up-to-date on recommended childhood vaccines.
Recommended Immunizations for Birth Through 6 Years Old, United States, 2025
< < Back to child schedule in parent-friendly format
Immunizations Recommended for All Children
¶ = Some children should get this dose of vaccine at this age depending on their dose series
| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 7 mos | 8 mos | 12 mos | 15 mos | 18 mos | 19 mos | 20-23 mos | 2-3 yrs | 4-6 yrs | 7 yrs | 8 yrs | 9 yrs | 10 yrs | 11 yrs | 12 yrs | 13 yrs | 14 yrs | 15 yrs | 16 yrs | 17 yrs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diphtheria, tetanus, acellular pertussis (DTaP < 7 yrs) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
5th dose
|
||||||||||||||||||||
| Tetanus, diphtheria, acellular pertussis (Tdap ≥ 7 yrs) |
1st dose
|
||||||||||||||||||||||||
| Haemophilus influenzae type b (Hib) |
1st dose
|
2nd dose
|
3rd dose¶
|
3rd/4th dose
|
|||||||||||||||||||||
| Pneumococcal conjugate (PCV15, PCV20) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
|||||||||||||||||||||
| Inactivated poliovirus (IPV < 18 yrs) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
|||||||||||||||||||||
| Measles, mumps, rubella (MMR) |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Varicella (VAR) |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Human papillomavirus (HPV) |
1st dose
|
||||||||||||||||||||||||
Immunizations Based on Shared Clinical Decision-Making
§ = Some children should get this dose of vaccine at this age depending on their dose series
| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 7 mos | 8 mos | 12 mos | 15 mos | 18 mos | 19 mos | 20-23 mos | 2-3 yrs | 4-6 yrs | 7 yrs | 8 yrs | 9 yrs | 10 yrs | 11 yrs | 12 yrs | 13 yrs | 14 yrs | 15 yrs | 16 yrs | 17 yrs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rotavirus (RV): RV1 (2-dose series), RV5 (3-dose series) |
1st dose
|
2nd dose
|
3rd dose§
|
||||||||||||||||||||||
| COVID-19 (1vCOV-mRNA, 1vCOV-aPS) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Influenza (IIV3, ccIIV3) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Influenza (LAIV3) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Hepatitis A (HepA) |
2-dose series
|
||||||||||||||||||||||||
| Hepatitis B (HepB)* |
1st dose
|
2nd dose
|
3rd dose
|
||||||||||||||||||||||
| Meningococcal ACWY |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Meningococcal B |
2 or 3 doses
|
||||||||||||||||||||||||
* For parents deciding whether to vaccinate for HepB in infants born to women who tested negative for the hepatitis B virus, it is suggested that the initial dose is administered no earlier than 2 months of age.